FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934
April 18, 2006
Commission File Number 001-14978
SMITH & NEPHEW plc
(Registrant's name)
15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)
[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
Form 20-F X Form 40-F
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
Yes No X
--- ---
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(7).]
Yes No X
--- ---
[Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
Yes No X
--- ---
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Smith & Nephew plc
(Registrant)
Date: April 18, 2006
By: /s/ Paul Chambers
-----------------
Paul Chambers
Company Secretary
Smith & Nephew Announces Timing Change of First Quarter Results Conference Call
18 April 2006
Smith & Nephew plc, (LSE: SN, NYSE: SNN), the global medical technology
business, announces a change in the timing of the first quarter results
conference call with financial analysts from 12.30pm BST/7.30am Eastern to 12.00
noon BST/7.00am Eastern on Thursday 27 April 2006. This change is a result of
clashes with other industry conference calls taking place on the same day. The
release of the announcement of first quarter results will remain at 11.00am BST/
6.00am Eastern on that day.
Enquiries
Smith & Nephew UK
Julie Allen Tel: +44 (0)20 7401 7646
Investor Relations Co-ordinator
Financial Dynamics UK
David Yates/Ben Atwell Tel: +44 (0)20 7831 3113
Financial Dynamics US
Jonathan Birt Tel: +1 212 850 5634
About us
Smith & Nephew is a global medical technology business, specialising in
Orthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephew
is a global leader in arthroscopy and advanced wound management and is one of
the fastest growing global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust. The company has over 8,500
employees and operates in 33 countries around the world generating annual sales
of $2.6 billion.